Forgot Password.
By Logging in, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Not a member? Sign Up
By Signing up, you are agreeing to the MedSearch Global Terms of Use and Privacy Policy.
Have an account? Log in
Back to Login? Log in
By registering in, you are agreeing to the MedSearch Global terms and condition and Privacy Policy.
Thinking of joining a study?
Register your interest
4068 results
Interventional
Phase4
70
w-3 fatty acid
L-carnitine
Control Diet
VA Office of Research and Development
Source: clinicaltrials.gov
Phase3
100
Rifaximin 550 MG Oral Tablet [XIFAXAN]
Placebo
Wake Forest University Health Sciences
Phase1
26
Autologous Anti-CD83 CAR T-cells
Biospecimen Collection
Chest Radiography
Computed Tomography
Cyclophosphamide
Echocardiography
Fludarabine Phosphate
Hydroxyurea
Leukapheresis
Lumbar Puncture
Positron Emission Tomography
Administration questionnaire
Roswell Park Cancer Institute
Not Applicable
15
Hearing Aid with standard noise reduction (NR_1)
Hearing Aid with NR_2
Hearing Aid with NR_3
Sebastian Griepentrog
167
EndoScell™ intraoperative handheld microscope
Peking University Cancer Hospital & Institute
660
patients will receive NPH education
primary care physicians (PCPs) will receive professional NPH education
A community health worker will assist PCP
Johns Hopkins Bloomberg School of Public Health
Phase2
40
Acetazolamide
Sanjay R Patel
Observational
30
Single Cell RNA Sequencing
Israelite Hospital Albert Einstein
Digital Therapeutic (Version 1)
Digital Therapeutic (Version 2)
Treatment as Usual (TAU)
Oui Therapeutics, Inc.
Exposure and Response Prevention
Icahn School of Medicine at Mount Sinai